On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.
about
The dopamine metabolite 3-methoxytyramine is a neuromodulatorThe involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatmentThe neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induces apoptosis in mouse nigrostriatal glia. Relevance to nigral neuronal death and striatal neurochemical changes.Does gamma-hydroxybutyrate inhibit or stimulate central DA release?Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration.Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.Dopamine synthesis in synaptosomes: relation of autoreceptor functioning to pH, membrane depolarization, and intrasynaptosomal dopamine content.Vitreal dihydroxyphenylacetic acid (DOPAC) as an index of retinal dopamine release.Dopac distribution and regulation in striatal dopaminergic varicosities and extracellular space.Chronic use of intracerebral dialysis for the in vivo measurement of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic acid.Changes in neurotransmitter levels associated with the deficiency of some essential amino acids in the diet.In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain.In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine.Susceptibility to subsequent episodes in spontaneous recurrence of methamphetamine psychosis.
P2860
Q21091097-E72FA008-93ED-4901-83C0-4045BB7DEC2FQ28343327-DF04D79F-7A47-4BCA-9DBD-E0100C926025Q33183865-55BD29C5-CB78-4F33-860E-13BFA3F3C074Q41325297-0DCB72EB-2D16-4E8D-BACE-2495B1987E38Q42008895-CD3BFC40-9544-4D2D-BF4E-214ABE8E444AQ42239842-64B6589D-91E5-4667-AF89-FADAD7AA2C76Q42462655-7830DF70-4392-4DFF-A11B-0E528C8BA1E7Q43548183-358F1B53-15BC-4D00-8453-2DF76853F884Q43878447-8A2CF859-581B-4366-AC18-5ACD1D6C62C4Q48391876-149D3005-E036-4E60-A10C-1997A09C451EQ48440323-A4122ED2-FDEF-4860-B0A9-3F360E92D691Q48589655-59497687-3B3D-4643-A0E9-84D826B6D612Q48712656-1BA893DA-D35C-445D-9B11-ED8056FAA322Q51073176-0DC4AAD7-E0E3-4C65-86AE-189D501C5FCD
P2860
On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
On the significance of endogen ...... mine release in the rat brain.
@en
On the significance of endogen ...... mine release in the rat brain.
@nl
type
label
On the significance of endogen ...... mine release in the rat brain.
@en
On the significance of endogen ...... mine release in the rat brain.
@nl
prefLabel
On the significance of endogen ...... mine release in the rat brain.
@en
On the significance of endogen ...... mine release in the rat brain.
@nl
P2860
P1476
On the significance of endogen ...... mine release in the rat brain.
@en
P2093
Westerink BH
P2860
P304
P356
10.1111/J.1471-4159.1982.TB08685.X
P407
P577
1982-03-01T00:00:00Z